Literature DB >> 30532837

Successful termination of recurrent ventricular arrhythmias by adaptive servo-ventilation in a patient with heart failure.

Shiro Yamada1, Mamoru Sakakibara1, Shouji Matsushima1, Akimichi Saito1, Tsuneaki Homma1, Arata Fukushima1, Yoshihiro Masaki1, Masaya Watanabe1, Hirofumi Mitsuyama1, Hisashi Yokoshiki1, Hiroyuki Tsutsui1.   

Abstract

A 60-year-old woman who underwent operation due to severe aortic stenosis with left ventricular dysfunction had frequent nonsustained ventricular tachycardia (NSVT) at night. She had an increased apnea-hypopnea index and a reduction in minimum O2 saturation during sleep, which was closely associated with the frequency of NSVT. Adaptive servo-ventilation (ASV) therapy improved sleep disorder breathing (SDB) and also reduced ventricular arrhythmias. These effects were associated with the attenuation of the sympathetic nerve activities by the analysis of heart rate variability. ASV is expected to be effective in the treatment of ventricular tachyarrhythmias in patients with heart failure and SDB.

Entities:  

Keywords:  Adaptive servo-ventilation; Heart failure; Sleep disorder breathing; Sympathetic nerve activity; Ventricular tachycardia

Year:  2011        PMID: 30532837      PMCID: PMC6265137          DOI: 10.1016/j.jccase.2011.01.001

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  16 in total

1.  Muscle nerve sympathetic activity during sleep and its change with arousal response.

Authors: 
Journal:  J Sleep Res       Date:  1992-09       Impact factor: 3.981

2.  Termination of recurrent ventricular tachycardia by continuous positive airway pressure ventilation.

Authors:  Yuichi J Shimada; Kazutoshi Sato; Sam Hanon; Paul Schweitzer
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-10       Impact factor: 1.468

3.  Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea.

Authors:  C M Ryan; K Usui; J S Floras; T D Bradley
Journal:  Thorax       Date:  2005-06-30       Impact factor: 9.139

4.  Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure.

Authors:  H Teschler; J Döhring; Y M Wang; M Berthon-Jones
Journal:  Am J Respir Crit Care Med       Date:  2001-08-15       Impact factor: 21.405

5.  Day-night pattern of sudden death in obstructive sleep apnea.

Authors:  Apoor S Gami; Daniel E Howard; Eric J Olson; Virend K Somers
Journal:  N Engl J Med       Date:  2005-03-24       Impact factor: 91.245

6.  Occult sleep-disordered breathing in stable congestive heart failure.

Authors:  S Javaheri; T J Parker; L Wexler; S E Michaels; E Stanberry; H Nishyama; G A Roselle
Journal:  Ann Intern Med       Date:  1995-04-01       Impact factor: 25.391

7.  Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations.

Authors:  S Javaheri; T J Parker; J D Liming; W S Corbett; H Nishiyama; L Wexler; G A Roselle
Journal:  Circulation       Date:  1998-06-02       Impact factor: 29.690

8.  Practice parameters for the use of portable monitoring devices in the investigation of suspected obstructive sleep apnea in adults.

Authors:  Andrew L Chesson; Richard B Berry; Allan Pack
Journal:  Sleep       Date:  2003-11-01       Impact factor: 5.849

9.  Influence of lung volume on sympathetic nerve discharge in normal humans.

Authors:  D R Seals; N O Suwarno; J A Dempsey
Journal:  Circ Res       Date:  1990-07       Impact factor: 17.367

10.  Continuous positive airway pressure treatment for obstructive sleep apnoea reduces resting heart rate but does not affect dysrhythmias: a randomised controlled trial.

Authors:  Sonya Craig; Justin C T Pepperell; Malcolm Kohler; Nicky Crosthwaite; Robert J O Davies; John R Stradling
Journal:  J Sleep Res       Date:  2009-06-22       Impact factor: 3.981

View more
  1 in total

1.  Carotid body denervation improves autonomic and cardiac function and attenuates disordered breathing in congestive heart failure.

Authors:  Noah J Marcus; Rodrigo Del Rio; Evan P Schultz; Xiao-Hong Xia; Harold D Schultz
Journal:  J Physiol       Date:  2013-11-18       Impact factor: 5.182

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.